Senomyx

Discovery of small molecules modulating chemosensory perception and the commercialization of products relevant to sensory experiences of taste and olfaction. Ongoing programs include discovery of novel salt, sweet, and umami enhancers, bitter antagonists, and odor blockers. Senomyx went public in June 2004. (NASDAQ:SNMX).